GeneDx Holdings Corp (NAS:WGS)
$ 74.86 -0.3 (-0.4%) Market Cap: 2.06 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 10.05 GF Score: 43/100

Q4 2023 GeneDx Holdings Corp Earnings Call Transcript

Feb 20, 2024 / 09:30PM GMT
Release Date Price: $5.24 (+3.76%)
Operator

Thank you for standing by, and welcome to the GeneDx fourth quarter 2023 earnings conference. (Operator Instructions) As a reminder, today's program is being recorded.

And now I'd like to introduce your host for today's program, Sabrina Dunbar, Chief of Staff. Please go ahead.

Sabrina Dunbar GeneDx Holdings Corp;Chief of Staff

Thank you, operator, and thank you to everyone for joining us today. On the call, we have Katherine Stueland, President and Chief Executive Officer; and Kevin Feeley, Chief Financial Officer.

Earlier today, GeneDx released financial results for the fourth quarter ended December 31, 2023, and shared guidance for the full year 2024. Before we begin, please take note of our cautionary statement. We may make forward-looking statements on today's call, including about our business plans, guidance, and outlook. Forward-looking statements inherently involve risks and uncertainties and only reflect our view as of today, February 20, and we are under no obligation to update.

When discussing our results, we refer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot